Global Rx-360 Consortium Aims To Curb Supply Chain Threats

Drug manufacturers formed the Rx-360 consortium as a vanguard in protecting the global supply chain of ingredients for Rx and nonprescription drug products from threats like the heparin adulteration potentially linked to 146 U.S. deaths in 2008

More from Archive

More from Pink Sheet